The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|August 1, 2008
The American Journal of Managed Care
- August 2008
- Volume 14
- Issue 8
Participant Disclosure (Am J Manag Care. 2008;14[suppl 8]:S241-S268)
Advertisement
Our July 2008 supplement on Biologics and Benefit Design, funded by Amgen Inc, (Am J Manag Care. 2008;14[suppl 8]:S241-S268), included an error of omission on the Participant Disclosures page.
The following disclosures for Robert Berglund should have been noted on S244:
Robert Berglund
Honoraria, Amgen Inc
Articles in this issue
over 18 years ago
A Meta-analysis Update: Percutaneous Coronary Interventionsover 18 years ago
Medicare HMO Impact on Utilization at the End of Lifeover 18 years ago
Flunking Asthma? When HEDIS Takes the ACTAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
2
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
3
No Surprises Act Arbitration Added $8.39B in 2025 Plan Obligations
4
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
5